Patent Challenges in Pharma
The discussion delves into the unique challenges of targeting pharmaceutical patents, emphasizing the risks involved in shorting companies based on patent validity. While the potential for reducing healthcare costs exists, particularly with expensive blockbuster drugs, the effectiveness of this strategy remains uncertain. The conversation also touches on the rare intersection of hedge funds and societal good, suggesting that if successful, this approach could benefit the broader public despite its profit-driven motives.In this clip
From this podcast
Odd Lots
Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?
Related Questions
What do you think about the pharmaceutical industry in the context of the episode Curing the Trust Problem with Mark Cuban and the clip Pharmaceutical Pricing Challenges?
How does the patent system work in relation to the episode Robin Feldman on Drug Patents, Generics, and Drug Wars and the clip Weak Patents and Generic Drugs?